Although this trial reported no significant differences in the primary efficacy endpoint, measured by changes in the ASIA motor score at 3 months post-intervention between the G-CSF and control groups, those at 6 and 12 months showed a trend towards better improvement in the G-CSF group [ 158 ].
1
—
—